Last reviewed · How we verify

NCT04776122

Usability of a Breathing-CBT Platform (CBT = Cognitive Behavioural Therapy)

Completed NA Last updated 1 March 2021
What this trial tests

NA trial testing Therapy in Breathing, Mouth in 10 participants. Completed in 30 July 2018.

Timeline
1 June 2018
Primary endpoint
30 June 2018
30 July 2018

Quick facts

Lead sponsorResMed
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment10
Start date1 June 2018
Primary completion30 June 2018
Estimated completion30 July 2018
Sites1 location across Australia

Drugs / interventions tested

Conditions studied

Sponsor

ResMed — full company profile →

Who can join

18 and older, any sex, with Breathing, Mouth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will examine the usability of a breathing platform in the home environment. It will be a randomized, open-label crossover study of 10 participants who will complete the CBT and breathing components in their home, prior to sleeping. Usability will be measured by scores assigned by participants. Qualitative feedback and compliance information will also be collected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Therapy

Trials testing the same drug.

Other recruiting trials for Breathing, Mouth

Currently open trials in the same condition.

Other ResMed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04776122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing